Bone Health in Patients with Breast Cancer: Recommendations from an Evidence-Based Canadian Guideline

Bone loss is common in patients with breast cancer. Bone modifying agents (BMAs), such as bisphosphonates and denosumab, have been shown to reverse or stabilize bone loss and may be useful in the primary and metastatic settings. The purpose of this review is to provide clear evidence-based strategie...

Descripción completa

Detalles Bibliográficos
Autores principales: Paterson, Alexander H. G., Shea-Budgell, Melissa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470150/
https://www.ncbi.nlm.nih.gov/pubmed/26237149
http://dx.doi.org/10.3390/jcm2040283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470150/
https://www.ncbi.nlm.nih.gov/pubmed/26237149
http://dx.doi.org/10.3390/jcm2040283

Ejemplares similares